PEN 250516 270.00C(PEN250516C270000) Stock Price Today

28.55
-2.45-7.90%

15min DelayClose May 2 16:00 ET

28.55High27.63Low

SymbolStock Name

PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry

WatchlistPaper Trade

Comments

Movers and Shakers

Feb 19 21:25

Columns Today's Pre-Market Movers and Top Ratings | MCI, WBA, PEN and More

Morning Movers
Gapping Up
$Super Micro Computer (SMCI.US)$ shares surged 8.2% in premarket trading after the company projected significant sales growth in 2026, driven by increased demand for AI servers.
$Walgreens Boots Alliance (WBA.US)$ shares jumped 14% after reports that a potential deal to sell the company to private equity firm Sycamore Partners may be back on the table.
$NVIDIA (NVDA.US)$ shares edged up 0.4% despite Presid...

Moomoo AI

Feb 23, 2024 01:42

Despite the high P/S ratio, shareholders are holding onto Penumbra's stocks due to its strong future revenue prospects. The strong revenue forecasts are expected to keep the share price buoyant unless the analysts have significantly misjudged the company's potential.

Penumbra, Inc.'s (NYSE:PEN) Earnings Haven't Escaped The Attention Of Investors

Chatterbox Moo

Nov 21, 2023 18:20

Columns Medical-device Stock Selloff Caused by Ozempic Fears Has Gone Too Far—Now They're Rebounding

A new generation of highly effective weight-loss and diabetes drugs known as GLP-1s has led Wall Street to spell doom for companies that have profited from obesity problem. However, the reaction on Wall Street has been extreme, creating opportunities for cooler heads, some analysts and investors say.
To be sure, drugs such as $Novo-Nordisk A/S (NVO.US)$'s Ozempic and Wegovy, and Eli Lilly's Mounjaro have p...

Moomoo AI

Nov 9, 2023 19:00

Penumbra's earnings outlook could be brighter than reflected in the statutory profit due to one-off items. The company's profitability this year shows a good sign after previous losses.

The Strong Earnings Posted By Penumbra (NYSE:PEN) Are A Good Indication Of The Strength Of The Business

Moomoo AI

Nov 4, 2023 01:00

Penumbra's low ROE and declining net income over five years hint at sub-par performance. The earnings' decline, despite profit retention, could imply a struggling business or high payout ratio. Analyst estimates, however, foresee a better earnings growth rate.

Is Penumbra, Inc.'s (NYSE:PEN) Recent Price Movement Underpinned By Its Weak Fundamentals?

PEN250516C270000

News

Comments